Global health

Uvax Bio Appoints Pedro Garbes, MD., as Vice President, Global Medical Lead

Retrieved on: 
Wednesday, September 13, 2023
Science, Biotechnology, Research, Pharmaceutical, AIDS, Health, Infectious Diseases, Clinical Trials, Vaccine, GSK plc, University, Senior, HIV, Bio, FISU World University Games, HIV-1, Allergan, COVID-19, Infection, Global health, AstraZeneca, Messenger, Administration, Sanofi Pasteur, Faculdade de Medicina da Universidade Federal de Minas Gerais, Gritstone bio, VLP, Rest, Virus, Master, Medicine

Uvax Bio LLC, a vaccine biotechnology company that utilizes its proprietary 1c-SApNP® vaccine design and manufacturing platform to produce protein-based VLP vaccines to fight viruses that threaten global health, announced today that Pedro Garbes, MD., has joined the company as Vice President, Global Medical Lead.

Key Points: 
  • Uvax Bio LLC, a vaccine biotechnology company that utilizes its proprietary 1c-SApNP® vaccine design and manufacturing platform to produce protein-based VLP vaccines to fight viruses that threaten global health, announced today that Pedro Garbes, MD., has joined the company as Vice President, Global Medical Lead.
  • Dr. Garbes joins Uvax Bio at a key inflection point as the company’s recombinant protein nanoparticle vaccines are advancing in development.
  • "We are pleased to have Pedro join our leadership team as we prepare to take our lead vaccines to the next stage of development.
  • Pedro Garbes brings to Uvax Bio over two decades of life sciences experience in clinical vaccine development, medical affairs, and medical/commercial strategy.

New Mountain Capital Appoints Industry Leader Sastry Chilukuri as Executive Advisor and Executive Chairman of Portfolio Company, Emmes

Retrieved on: 
Tuesday, September 12, 2023
Biotechnology, Finance, Health, Asset Management, Artificial Intelligence, Health Technology, Professional Services, Technology, Private equity, New Mountain, Contract research organization, GE HealthCare, Public, Intelligence, Global health, Research, Public sector, Dassault Systèmes, Growth, Federation, AI, Medidata Solutions, Financial services, Pharmaceutical industry, EMMS International, Chilukuri Narayana Rao

New Mountain Capital (“New Mountain”), a leading growth-oriented investment firm with more than $45 billion in assets under management, today announced that Sastry Chilukuri has joined its team as an Executive Advisory Council Member and has been named Executive Chairman of Emmes.

Key Points: 
  • New Mountain Capital (“New Mountain”), a leading growth-oriented investment firm with more than $45 billion in assets under management, today announced that Sastry Chilukuri has joined its team as an Executive Advisory Council Member and has been named Executive Chairman of Emmes.
  • In these roles, Chilukuri will oversee the digitization and artificial intelligence (AI)-enablement of Emmes and other New Mountain Capital portfolio companies.
  • I’m excited about the opportunity to AI-enable Emmes as well as other New Mountain Capital portfolio companies,” said Chilukuri.
  • New Mountain Capital is a New York-based investment firm that emphasizes business building and growth, rather than debt, as it pursues long-term capital appreciation.

Ensuring Safe Return to Campus with Health and Security Guidelines for the Education Community from International SOS

Retrieved on: 
Monday, September 11, 2023
COVID-19, Other Professional Services, Other Education, University, Consulting, Other Travel, Education, Lodging, Professional Services, Destinations, Mental Health, General Health, Travel, Infectious Diseases, Health, Learning, Communication, Emergency, International, Health care, Infection, Ageing, Global health, History, Ventilation, Security, School, Student, Risk, International SOS, Faculty, Knowledge, Safety, Tutoring, Nursing

With the world navigating the impacts of various global health crises and security concerns, International SOS , the world’s leading health and security company, highlights the importance for education organisations to prioritise the health, security and wellbeing of their community.

Key Points: 
  • With the world navigating the impacts of various global health crises and security concerns, International SOS , the world’s leading health and security company, highlights the importance for education organisations to prioritise the health, security and wellbeing of their community.
  • Dr Kate O’Reilly, Medical Director at International SOS, comments, “The return to campus is an exciting time for students and employees.
  • International SOS shares the following health and safety tips for schools and universities to consider when preparing for return to campus:
    Implementing health guidelines: Collaborate closely with local health authorities and experts to implement comprehensive health guidelines.
  • To assess your return to campus readiness and identify gaps that reside within your current Return to Campus plan, click here.

Pacific Dental Services Foundation and Owlverick's Launch Coffee Fundraiser

Retrieved on: 
Wednesday, September 13, 2023
Poverty, Education, Malnutrition, Global health, Sale, PDS, Dental care, Coffee, Dental, Female

IRVINE, Calif., Sept. 13, 2023 /PRNewswire/ -- Pacific Dental Services® (PDS) Foundation and Owlverick's Coffee have jointly launched the "Love People, Love Coffee" fundraising campaign, supporting the PDS Foundation's International Dentistry Program in Xenacoj, Guatemala, through the sale of coffee.

Key Points: 
  • IRVINE, Calif., Sept. 13, 2023 /PRNewswire/ -- Pacific Dental Services® (PDS) Foundation and Owlverick's Coffee have jointly launched the "Love People, Love Coffee" fundraising campaign, supporting the PDS Foundation's International Dentistry Program in Xenacoj, Guatemala, through the sale of coffee.
  • Guatemala faces an overwhelming demand for dental care, especially among rural residents who encounter challenges in accessing it.
  • Recognizing the need for oral health care within the country, the PDS Foundation established a cost-free dental clinic in Xenacoj in 2015.
  • "Love People, Love Coffee" aims to enhance accessibility to these essential oral healthcare services.

Infleqtion, UChicago, and MIT Unite to Develop Breakthrough Cancer Solutions with AI and Quantum Algorithms

Retrieved on: 
Wednesday, September 13, 2023
University, Trust, QC, Wellcome Trust, Pathology, Cancer, ML, University of Chicago, Hope, Global health, Research, MIT, Genomics, Associate, Assistant, Thought, Data analysis, Patient, Algorithm, Physics, Artificial intelligence, Knowledge, AI, Health, Quantum, Death, Computer science, Seymour, Medical device, Medical imaging, Medicine

CHICAGO, Sept. 13, 2023 /PRNewswire/ -- Infleqtion, the world's quantum information company, today announced that it had been awarded funding from Wellcome Leap's Quantum for Bio (Q4Bio) program with a team of renowned researchers and medical doctors at the University of Chicago (UChicago) and Massachusetts Institute of Technology (MIT). This collaborative effort aims to transform cancer care by harnessing the power of artificial intelligence (AI) and quantum algorithms to drive personalized diagnostics and treatments. Founded by the Wellcome Trust in 2020, Wellcome Leap is a U.S. non-profit that builds and executes bold, unconventional programs designed to increase the number and speed of breakthroughs in human health. 

Key Points: 
  • This collaborative effort aims to transform cancer care by harnessing the power of artificial intelligence (AI) and quantum algorithms to drive personalized diagnostics and treatments.
  • The team led by Infleqtion, a company with extensive experience in commercializing quantum technologies, includes leaders in quantum computing (QC), algorithm development, multimodal genomics, and clinical cancer care.
  • Dr. Aram Harrow, a Professor of Physics at MIT, is a renowned quantum algorithms developer.
  • Together, the team is uniquely positioned to leverage their powerful computational resources to develop quantum cancer biomarker algorithms.

New Multinational Health Equity Data Unlocks Intersection of Community Insights, Unmet Needs and Business Impact to Achieve Health Equity

Retrieved on: 
Tuesday, September 12, 2023
NCQA, Internet, Public, Health equity, MBA, Global health, Native Americans, Patient, Rutgers School of Public Health, Digital, Empathy, Fatigue, Organization, Religion, Greater, Culture, WebMD, Disability, Health promotion, Research, Language, Lucid, Emotional intelligence, Migrant, Social media, Private sector, Physical disability, International, Health education, Health, Business, Nursing, African Americans, Public health, MPH, Intersection, Digital divide, Doctor of Public Health, Education, Digital technology, BDO, Trust, Community, Rutgers School of Communication and Information, Health literacy, Community health worker, Retail, MD, CINT, Refugee, Atlantic Ocean

NEW YORK, Sept. 12, 2023 /PRNewswire/ -- A new global health equity data report released today by Omnicom PR Group (OPRG) finds widespread lack of trust in healthcare systems among non-white, LGBTQAI+ and immigrant communities and that a clear majority report experiencing explicit discrimination when seeking healthcare.

Key Points: 
  • Survey data shows that 62% of all respondents report experiencing explicit discrimination when seeking healthcare and 77% reported a lack of trust in health systems.
  • The data also shows that explicit discrimination, lack of trust and the digital divide are more pronounced among non-white, LGBTQAI+ and immigrant communities.
  • This data will inform academic curricular, intersectoral initiatives and business strategies that help advance health equity."
  • Topline data also shows – at the community level – gender, race/ethnicity, LGBTQIA+ and immigration status are palpable social determinants of health equity, and lived experiences differ among specific communities and countries.

Gates Foundation Goalkeepers Report Says Seven Innovations Could Save 2 Million Mothers and Babies by 2030

Retrieved on: 
Tuesday, September 12, 2023
Goalkeeper, United Nations Sustainable Development Group, Poverty, Pregnancy, IV, Education, Infection, Policy, COVID-19, Woman, Global health, Research, Melinda French Gates, Maternal death, Bill & Melinda Gates Foundation, Sustainable Development Goals, Mother, Death, Azithromycin, ACS, Child, Anemia, Internal bleeding, Bill, Mortality, Infant, United, Health, Food security, Coal, Birth control, Nursing, Dietary supplement

SEATTLE, Sept. 12, 2023 /PRNewswire/ -- The Bill & Melinda Gates Foundation today released its seventh annual Goalkeepers Report, describing where the world has collectively fallen short at the halfway point for achieving the United Nations Sustainable Development Goals (SDGs), and where innovation and investment can fuel progress, particularly in the fight against the global epidemic of maternal and child mortality.

Key Points: 
  • Co-authored by foundation Co-chairs Melinda French Gates and Bill Gates, the report highlights new data that shows the potential of scaling up global access to seven innovations and practices that address the leading causes of maternal and newborn deaths.
  • "By making new innovations accessible to those who need them most, 2 million additional lives could be saved by 2030, and 6.4 million lives by 2040.
  • That's 2 million families spared an unimaginable heartbreak—and 2 million more people who can shape and enrich our world," they write.
  • Many of the life-saving innovations and practices highlighted in the report can be delivered by midwives and birth attendants in communities.

Gates Foundation Goalkeepers Report Says Seven Innovations Could Save 2 Million Mothers and Babies by 2030

Retrieved on: 
Tuesday, September 12, 2023
Goalkeeper, United Nations Sustainable Development Group, Poverty, Pregnancy, IV, Education, Infection, Policy, COVID-19, Woman, Global health, Research, Melinda French Gates, Maternal death, Bill & Melinda Gates Foundation, Sustainable Development Goals, Mother, Death, Azithromycin, ACS, Child, Anemia, Internal bleeding, Bill, Mortality, Infant, United, Health, Food security, Coal, Birth control, Nursing, Dietary supplement

SEATTLE, Sept. 12, 2023 /PRNewswire/ -- The Bill & Melinda Gates Foundation today released its seventh annual Goalkeepers Report, describing where the world has collectively fallen short at the halfway point for achieving the United Nations Sustainable Development Goals (SDGs), and where innovation and investment can fuel progress, particularly in the fight against the global epidemic of maternal and child mortality.

Key Points: 
  • Co-authored by foundation Co-chairs Melinda French Gates and Bill Gates, the report highlights new data that shows the potential of scaling up global access to seven innovations and practices that address the leading causes of maternal and newborn deaths.
  • "By making new innovations accessible to those who need them most, 2 million additional lives could be saved by 2030, and 6.4 million lives by 2040.
  • That's 2 million families spared an unimaginable heartbreak—and 2 million more people who can shape and enrich our world," they write.
  • Many of the life-saving innovations and practices highlighted in the report can be delivered by midwives and birth attendants in communities.

Prime Minister of the Republic of Serbia Visits SK bioscience to Establish Partnership for Vaccine Localization

Retrieved on: 
Friday, September 8, 2023
Vaccine, KK Zdravlje, Partnership, KOTRA, Public, Biotechnology, Global health, Government, Biodiversity, Republic, Investment, MOU, Health, Environment, Government of Serbia, Forestry, Pharmaceutical industry, Drug

SK bioscience signed a memorandum of understanding with the Serbian government and Frontier Biopharma to support the vaccine manufacturing environment in Serbia by utilizing its vaccine R&D, manufacturing, and commercial capabilities.

Key Points: 
  • SK bioscience signed a memorandum of understanding with the Serbian government and Frontier Biopharma to support the vaccine manufacturing environment in Serbia by utilizing its vaccine R&D, manufacturing, and commercial capabilities.
  • SEONGNAM, South Korea, Sept. 8, 2023 /PRNewswire/ -- SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that Ana Brnabić, Prime Minister of the Republic of Serbia (Serbia) has visited the SK bioscience headquarters and signed a memorandum of understanding (MOU) with the company to establish a strategic partnership in vaccine development and manufacturing between the two countries.
  • This marks the first visit by a Serbian prime minister to South Korea in 13 years, dating back to 2010.
  • Along with the MOU, SK bioscience, and Frontier Biopharma agreed to sign a contract within the year for collaborating to establish vaccine manufacturing facilities in Serbia with support from the Serbian government.

Prime Minister of the Republic of Serbia Visits SK bioscience to Establish Partnership for Vaccine Localization

Retrieved on: 
Friday, September 8, 2023
Vaccine, KK Zdravlje, Partnership, KOTRA, Public, Biotechnology, Global health, Government, Biodiversity, Republic, Investment, MOU, Health, Environment, Government of Serbia, Forestry, Pharmaceutical industry, Drug

SK bioscience signed a memorandum of understanding with the Serbian government and Frontier Biopharma to support the vaccine manufacturing environment in Serbia by utilizing its vaccine R&D, manufacturing, and commercial capabilities.

Key Points: 
  • SK bioscience signed a memorandum of understanding with the Serbian government and Frontier Biopharma to support the vaccine manufacturing environment in Serbia by utilizing its vaccine R&D, manufacturing, and commercial capabilities.
  • SEONGNAM, South Korea, Sept. 8, 2023 /PRNewswire/ -- SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that Ana Brnabić, Prime Minister of the Republic of Serbia (Serbia) has visited the SK bioscience headquarters and signed a memorandum of understanding (MOU) with the company to establish a strategic partnership in vaccine development and manufacturing between the two countries.
  • This marks the first visit by a Serbian prime minister to South Korea in 13 years, dating back to 2010.
  • Along with the MOU, SK bioscience, and Frontier Biopharma agreed to sign a contract within the year for collaborating to establish vaccine manufacturing facilities in Serbia with support from the Serbian government.